Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Should You Buy The Phoenix Companies, Inc. (PNX)?: Life Partners Holdings, Inc. (LPHI)

Page 1 of 2

Is The Phoenix Companies, Inc. (NYSE:PNX) a buy, sell, or hold? The best stock pickers are buying. The number of long hedge fund bets improved by 2 in recent months.


In the financial world, there are a multitude of indicators market participants can use to track Mr. Market. Two of the most underrated are hedge fund and insider trading activity. At Insider Monkey, our studies have shown that, historically, those who follow the top picks of the best fund managers can beat the S&P 500 by a solid amount (see just how much).

Equally as important, positive insider trading activity is another way to parse down the investments you’re interested in. Just as you’d expect, there are lots of reasons for a corporate insider to get rid of shares of his or her company, but only one, very obvious reason why they would initiate a purchase. Plenty of empirical studies have demonstrated the useful potential of this strategy if shareholders know what to do (learn more here).

With all of this in mind, let’s take a glance at the recent action surrounding The Phoenix Companies, Inc. (NYSE:PNX).

Hedge fund activity in The Phoenix Companies, Inc. (NYSE:PNX)

Heading into 2013, a total of 8 of the hedge funds we track held long positions in this stock, a change of 33% from the third quarter. With hedge funds’ sentiment swirling, there exists an “upper tier” of notable hedge fund managers who were boosting their holdings significantly.

Of the funds we track, Toscafund Asset Management, managed by Martin Hughes, holds the biggest position in The Phoenix Companies, Inc. (NYSE:PNX). Toscafund Asset Management has a $8 million position in the stock, comprising 6.1% of its 13F portfolio. On Toscafund Asset Management’s heels is Jim Simons of Renaissance Technologies, with a $1 million position; 0.1% of its 13F portfolio is allocated to the stock. Some other hedgies that are bullish include Gifford Combs’s Dalton Investments, Joseph A. Jolson’s Harvest Capital Strategies and Cliff Asness’s AQR Capital Management.

With a general bullishness amongst the heavyweights, some big names have jumped into The Phoenix Companies, Inc. (NYSE:PNX) headfirst. Dalton Investments, managed by Gifford Combs, assembled the largest position in The Phoenix Companies, Inc. (NYSE:PNX). Dalton Investments had less than $1 million invested in the company at the end of the quarter. Ken Griffin’s Citadel Investment Group also initiated a less than $1 million position during the quarter.

How have insiders been trading The Phoenix Companies, Inc. (NYSE:PNX)?

Insider purchases made by high-level executives is best served when the company in question has experienced transactions within the past half-year. Over the last six-month time frame, The Phoenix Companies, Inc. (NYSE:PNX) has seen zero unique insiders purchasing, and zero insider sales (see the details of insider trades here).

Let’s also examine hedge fund and insider activity in other stocks similar to The Phoenix Companies, Inc. (NYSE:PNX). These stocks are Life Partners Holdings, Inc. (NASDAQ:LPHI), Kansas City Life Insurance Co (NASDAQ:KCLI), Citizens, Inc. (NYSE:CIA), Imperial Holdings, Inc. (NYSE:IFT), and Independence Holding Company (NYSE:IHC). All of these stocks are in the life insurance industry and their market caps are similar to PNX’s market cap.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!